aDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway

bDepartment of Clinical Pharmacology and Therapeutics, St James’ Hospital, Dublin

cCentre for Research in Medical Devices (CÚRAM, SFI 13/RC/2073_P2) and Health Economics and Policy Analysis Centre, University of Galway, Ireland

dCentre for Endocrinology, Diabetes and Metabolism

eDepartment of Nephrology, Saolta University Healthcare Group (SUHCG), Galway University Hospitals

fDepartment of Cardiology, School of Medicine, University of Galway

gNational Institute for Prevention and Cardiovascular Health, Galway, Ireland

Correspondence to Dr Louise Rabbitt, University of Galway, Galway, Ireland. E-mail: [email protected]

Abbreviations: aTRH, apparent treatment-resistant hypertension; AVS, adrenal vein sampling; BP, blood pressure; HSE, Health Service Executive; LC-MS/MS, liquid chromatography mass spectrometry; MDT, multidisciplinary team; SIT, saline infusion test; TAS, Treatment Abroad Scheme

Received 9 December, 2022

Revised 27 June, 2023

Accepted 25 July, 2023

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).